Ahead of the first Zantac lawsuit trials, slated to begin next year, investors sold off Sanofi, GlaxoSmithKline and Pfizer stocks, anticipating massive court losses and costs.
Makers of brand-name drugs want a federal judge to exclude expert witnesses for plaintiffs, seeking a summary judgment to have Zantac cancer risk lawsuits dismissed before they can make it…
A federal judge has scheduled hearings over Zantac cancer lawsuit Daubert motions for September.
A federal judge is calling on parties in Zantac cancer litigation to finalize a registry of potential plaintiffs and their information as the lawsuits enter the latter stages of pretrial…
Plaintiffs have identified five types of cancer which will be pursued in federal Zantac lawsuits, including bladder cancer, esophageal cancer, gastric cancer, liver cancer and pancreatic cancer.
Parties involved in litigation over the cancer risks of the heartburn drug Zantac will take part in a Zantac Science Day today and tomorrow in federal court.
A pool of 200 randomly selected Zantac cancer claims will form the initial discovery pool, from which the first bellwether cases will be selected.
A federal judge has called for a "Science Day" to help explain to the Court the scientific concepts behind Zantac, NDMA and the alleged health risks which led to the…
Parties involved in Zantac cancer litigation will meet next week to discuss plans for selecting potential bellwether test cases to go before juries.
A federal judge has ruled Zantac class action lawsuits calling for defendants to pay for the costs of medical monitoring for potential cancer, and to be held responsible for consumers'…